Tharimmune, Inc. (NASDAQ:THAR) shares are trading lower Tuesday after the company announced it has entered into a $5.3 million securities purchase agreement.
What To Know: Tharimmune said it entered into a securities purchase agreement for a registered direct offering of about $5.35 million in securities, consisting of 1,188,888 shares of common stock or equivalents at $4.50 per share.
The offering is expected to close on Aug. 27, subject to customary conditions. The company also agreed to pay its placement agents, President Street Global and RF Lafferty & Co., a 10% cash fee from the proceeds.
How To Buy Tharimmune Shares
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Tharimmune's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
See Also: What’s Going On With Interactive Brokers Stock Today?
THAR Price Action: At the time of writing, Tharimmune shares are trading 16.21% lower at $6.46, according to data from Benzinga Pro.
Image via Shutterstock
